Drugmaker Eli Lilly (LLY) has had a nice run in the Favored zone of the SIA S&P 100 Index Report where it holds the #1 ranking now. LLY has the best 1 day, 1 week, and 1 month performance out of all the holdings in the Report after a strong Q2 Earnings Report. Eli Lilly moved into the Favored zone in early April of 2023 and rose to one of the top holdings in the report after just a month.